Possible effects of DE implementation in India
Sankar Sundaram, Professor of Pharmaceutical Sciences, JSS University, talks about data exclusivity and if effective then how it…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Melanoma treatment market value to more than quadruple to $5.64 bn by 2023: GlobalData
The global treatment market for melanoma will expand more than fourfold in value from $1.34 billion in 2013 to reach an estimated…
Breathing Jaan into JanAushadhi
The government plans to re-brand the Jan Aushadhi initiative by opening 1000 centres across India by this June. Will this breathe…
PSU Vaccine Units: A Ray of Hope?
HLL Biotech launched two vaccines this year and is also working full throttle towards reviving three vaccine-manufacturing PSUs.…
MSF takes to social media to pressurise GSK, Pfizer to cut price of flu shot
Urges public to #AskPharma how developing countries can get ‘A FAIR SHOT’ when vaccine prices are being kept secret
India may go to WTO over EU’s drug suspension order of 700 generics
India is examining whether to take up with WTO the EU’s suspension order for sale of about 700 generic drugs which were approved…
Janssen India launches Invokana to treat type II diabetes
Invokana belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors
Zydus to tie up with US-based research centre
To develop a vaccine against visceral leishmaniasis
Hilleman Laboratories to extend its thermostable formulations to other vaccines
The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020
PEL to acquire majority equity stake in Health SuperHiway
The investment will be made in two tranches